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Abstract
Background: Mesenchymal stromal cells (MSCs) are multipotent and have great potential in cell therapy. Previously
we reported the differentiation potential of human MSCs into hepatocytes in vitro and that these cells can rescue
fulminant hepatic failure. However, the conventional static culture method neither maintains growth factors at an
optimal level constantly nor removes cellular waste efficiently. In addition, not only is the duration of differentiating
hepatocyte lineage cells from MSCs required to improve, but also the need for a large number of hepatocytes for
cell therapy has not to date been addressed fully. The purpose of this study is to design and develop an innovative
microfluidic device to overcome these shortcomings.
Methods: We designed and fabricated a microfluidic device and a culture system for hepatic differentiation of
MSCs using our protocol reported previously. The microfluidic device contains a large culture chamber with a
stable uniform flow to allow homogeneous distribution and expansion as well as efficient induction of hepatic
differentiation for MSCs.
Results: The device enables real-time observation under light microscopy and exhibits a better differentiation efficiency
for MSCs compared with conventional static culture. MSCs grown in the microfluidic device showed a higher level of
hepatocyte marker gene expression under hepatic induction. Functional analysis of hepatic differentiation demonstrated
significantly higher urea production in the microfluidic device after 21 days of hepatic differentiation.
Conclusions: The microfluidic device allows the generation of a large number of MSCs and induces hepatic
differentiation of MSCs efficiently. The device can be adapted for scale-up production of hepatic cells from
MSCs for cellular therapy.
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Background
Liver transplantation is the only definitive treatment for
end-stage liver diseases [1]. However, the lack of donor
organs has been a major obstacle to the treatment
modality. Besides, the long-term use of immuno-
suppressants after liver transplantation also brings
undesired adverse effects [2]. For these reasons, alterna-
tive treatment options are desired. Cell therapy, which
offers a potential solution to the problem of donor
shortage, has become highly attractive in recent years
along with the rapid progress in stem cell technology.
However, the unsolved ethical concerns and controver-
sies over the use of human embryos to derive embryonic
stem cells (ESCs) have substantially hampered the progress
of their clinical applications, not to mention that ESCs are
allogeneic in nature and may require further immue-
suppression treatment after implantation. Mesenchymal
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stromal cells (MSCs), which can be obtained from a num-
ber of somatic tissues including adipose tissue [3, 4], am-
niotic fluid [5, 6], placenta [7], and umbilical cord blood
[8], are easily available. We have previously reported the dif-
ferentiation potential of human MSCs into hepatocytes in
vitro based on a novel two-step protocol [8, 9]; these cells
can rescue fulminant hepatic failure induced by CCl4 [10].
Recently, a number of studies have used similar protocols
for hepatic differentiation of MSCs based on our previous
reports [11–14]. About 4–6 weeks are required to complete
the hepatic differentiation process with these protocols. In
addition, the need for a large number of hepatocytes for cell
therapy has not been addressed fully in these studies.
Shear stress and fluid friction force generated from con-
tinuous fluid flow may significantly affect hepatic differenti-
ation of MSCs because liver regeneration in vivo is related
to portal pressure, reflecting fluid shear stress [15]. How-
ever, very few studies have examined the effects of fluid
shear stress on hepatic differentiation. Therefore, it is valu-
able to investigate hepatic differentiation of MSCs under
continuous fluid flow using a microfluidic device which
mimics the shear flow in the microenvironment. Microflui-
dic devices have been utilized in cell culture [16–18], cell
differentiation [19–22], dynamic gene expression [23, 24],
and test of cellular response to chemical gradients [25–27].
Studies of hepatic differentiation from MSCs using micro-
fluidic devices [20] and bioreactors [28–40], together with
3D scaffolds [41], have been reported. However, there are
shortcomings when using conventional microfluidic devices
to promote hepatic differentiation. First, an uneven flow in
a small culture chamber may affect the quality and yield of
differentiated cells [20]. Second, cell injection through seed-
ing microchannels causes an uneven cell distribution which
could affect cellular interaction and therefore influence dif-
ferentiation [17, 19, 20, 26, 42–48]. In addition, when cell
injection is completed during the injection processes, some
cells still remain in the injection microchannel and are not
delivered into the culture chamber. Thus, it is imperative to
develop an innovative microfluidic device that minimizes
these limitations.
To solve the aforementioned problems, we developed a
novel bio-microfluidic device system to enhance the hep-
atic differentiation capacity of MSCs. The microfluidic
device can also improve cell distribution and scale-up cell
productions. We further compared the performance of
the new system with that of the classic system.
Methods
Design and fabrication of the microfluidic device
and culture system
The features of the microfluidic device include an open-
cover design, use of a laser direct writing (LDW) technique,
an air bubble-removal design, and a choice of materials. An
open-cover design, in which the microfluidic device and
the culture substrate with a patterned cell culture region
were sealed by negative pressure, was adopted in order to
homogeneously distribute the cells onto the culture sub-
strate. A cell loading device fabricated by a LDW technique
(CO2 laser machine, ILS-II; Laser Tools and Techniques,
Hsinchu, Taiwan) was performed to pattern the cell culture
region to ensure a good match between the cell culture re-
gion and the culture chamber (Fig. 1b). The cells were then
seeded by the conventional method and allowed to attach
onto the substrate. After attaching the cells to the substrate,
the loading device was removed and the microfluidic device
was assembled. The assembly procedure was simple and
the setup time was less than 5 minutes. To assure a long-
term culture without interference, an air bubble-removal
structure in the microchannel was used to avoid injection
of air bubbles into the culture chamber. Besides, the trans-
parent feature of our device allowed the cell morphology to
be observed easily in real time. In brief, this device enables
a homogeneous cell distribution, large culture chamber,
rapid development time, rapid operation time, and real-
time observation under an optical microscope.
The microfluidic device was designed to have a culture
chamber dimension of 10 mm× 40 mm× 350 μm (width ×
length × height), with a culture area of 400 mm2. The
device was assembled in five layers (Fig. 1) consisting of a
lower layer of a culture substrate, on top of an intermediate
layer formed by two patterned glass and two patterned
polydimethylsiloxane (PDMS) membranes (Sylgard 184;
DowCorning, Midland, MI, USA), with a top layer of poly-
methyl methacrylate (PMMA), including three adaptors
for producing the vacuum, medium inlet, and outlet.
The PDMS membranes were prepared and fabricated
according to the manufacturer’s instructions. These
PDMS membranes were patterned by a CO2 laser ma-
chine and the glass was patterned by an ultrasonic dril-
ling machine (LUD-1200; Lapidary & Sonic Enterprises,
Taipei, Taiwan). The substrate was made from a poly-
styrene plate (PS) (25 mm × 75 mm) cut from a culture
dish using a CO2 laser. Finally, the patterned glass and
PDMS were bonded together by a plasma treatment
system (PX-250; Nordson, Westlake, OH, USA) and
stuck to the PMMA adaptor with double-sided tape to
completely assemble the microfluidic device. The micro-
fluidic device, which included a cell culture chamber, a
vacuum, and air bubble trap regions, was placed on top of
the PS culture substrate. The function of the vacuum re-
gion was to seal the culture substrates within the micro-
fluidic device by negative pressure. The pressure
applied for sealing is about 85 mmHg. For future
large-scale studies, the culture chamber can be further
scaled up (up to now, its maximal culture area is
32,400 mm2, as shown in Additional file 1: Figure S1).
In addition, the device was sterilized by γ-ray radiation
before the experiments.
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The assembled microfluidic culture system included
the actual microfluidic device with a thermal sensor and
regulator, a syringe pump, an inlet connecting the syr-
inge for culture medium injection, a separate outlet con-
nected to the waste tube, and a vacuum (Fig. 2a, b). The
device was connected to a time-lapse microscope for
real-time observation, attributed to the transparency of
the device chamber. The temperature controller ensures
a stable temperature of the culture chamber. The syr-
inge pump supplied fresh medium into the system, and
the time-lapse microscope allowed real-time observation
of the cellular morphology of MSCs during hepatic
differentiation.
Cultivation of MSCs
MSCs were harvested from the bone marrow of postna-
tal 7-week-old C57BL/6 J mice (National Laboratory
Animal Center, Taipei, Taiwan). Approval for the experi-
ment was obtained from the Taipei Veterans General
Hospital Institutional Animal Care and Use Committee
(IACUC) regarding the use of animals prior to com-
mencement of the experiments. For maintenance and
Fig. 1 Design of the microfluidic device and flow field rate simulation. a Components of the microfluidic device assemblage for cell culture and
induction of hepatic differentiation of MSCs. b Schematic illustration of the cell culture procedure to induce hepatic differentiation using the
microfluidic device. Cells were initially seeded unto the cell-loading device and allowed to adhere onto the substrate (a). After 24 hours, the cell
loading device was aseptically removed and the substrate was assembled with the other microfluidic components (b), cultured in hepatic induction
medium and monitored by time-lapse microscopy (c). c Simulation of medium diffusion in a pre-established flow field. The flow field (green) shows a
uniform flow profile in the culture chamber of the device. d Actual flow field area subjected to two flow rates (100 and 500 μl/hour) during culture
medium replacement. The medium flow rate of 100 μl/hour from left to right starts upon injection of the culture medium. Addition replacement
at t = 0 minutes (a), replacement progression at t = 10 minutes (b) and t = 20 minutes (c), and complete replacement at t = 30 minutes. The flow rate
of 500 μl/hour (lower panel) shows start of the replacement, t = 0 minutes (e). Replacement progression at t = 2 minutes (f) and t = 4 minutes (g).
Complete replacement at t = 6 minutes (h). e Schematic representation in lateral view of air bubble removal by negative pressure during injection of
culture medium into the cell culture chamber. PDMS polydimethylsiloxane, PMMA polymethyl methacrylate
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culture expansion, MSCs were maintained in Dulbec-
co’s modified Eagle’s medium with 1000 mg/L glucose
(LG-DMEM; Sigma-Aldrich, St. Louis, MO, USA) sup-
plemented with 10 % fetal bovine serum (FBS; Gibco
Invitrogen, Carlsbad, CA, USA), 100 units/ml penicillin,
100 μg/ml streptomycin, 2 mM L-glutamine (Gibco
Invitrogen), 10 ng/ml basic fibroblast growth factor
(bFGF; Sigma-Aldrich), and 10 ng/ml epidermal growth
factor (EGF; R&D Systems, Minneapolis, MN, USA).
Cells were seeded at a density of 3 × 103 cells/cm2 (30–
40 % confluence). They were subcultured and expanded
when reaching 80–90 % confluence. Confluent cells
were detached with 0.1 % trypsin-EDTA (Gibco Invitro-
gen), rinsed twice with PBS, and centrifuged at 200 × g
for 5 minutes. Cell pellets were rinsed twice with PBS
and resuspended in culture medium. The cells were re-
seeded at a density of 8 × 103 cells/cm2 prior to hepatic
differentiation under the same culture conditions. The
culture medium was replaced three times a week. All
cultures were maintained at 37 °C in a humidified at-
mosphere containing 5 % CO2.
Proliferation and hepatic differentiation of MSCs on the
microfluidic device
The procedures for proliferation and hepatic differen-
tiation of MSCs on the culture dish and the micro-
fluidic device are described in the supplementary
material (Additional file 1: Figure S2). Hepatic differ-
entiation was initiated using the two-step protocol we
reported previously [9]. Mouse MSCs were used for
hepatic differentiation and therefore the differentiation
time is about 3–4 weeks [49]. Step-1 induction
medium, consisting of Iscove’s modified Dulbecco’s
medium (IMDM; Gibco BRL, Grand Island, NY, USA)
supplemented with 20 ng/ml hepatocyte growth factor
(HGF; R&D Systems), 10 ng/ml bFGF, 0.61 g/L nico-
tinamide (Sigma-Aldrich), and 100 units/ml penicillin,
100 μg/ml streptomycin, 2 mM L-glutamine, was used
for induction in the first 7 days. Step-2 maturation
medium, consisting of IMDM supplemented with
20 ng/ml oncostatin M (ProSpec, East Brunswick, NJ,
USA), 1 μmol/L dexamethasone (Sigma-Aldrich), and
50 mg/ml insulin–transferrin–selenium (6.25 mg/ml
insulin, 6.25 mg/ml transferrin, 6.25 ng/ml selenious
acid, ITS+ premix; Becton Dickinson, Franklin Lakes,
NJ, USA), was used for induction for 2 weeks. During
the hepatic differentiation, induction medium was
supplied from the syringe and injected into the chamber
of the microfluidic device through the pipeline, and the
outlet was connected to the waste tube. Cellular waste
products were removed continuously inside the chamber.
The flow rate was 100 μl/hour. For the control group,
MSCs were cultured on the PS without continuous flow
and were induced by the same protocol.
Fig. 2 Assemblage of the complete microfluidic system for cell culture and time-lapse observation of MSC hepatic differentiation. a Actual
microfluidic system for cell culture. Insert shows the presence of a thermal sensor attached to the microfluidic device for temperature regulation.
b Developed microfluidic system. The culture system including the designed microfluidic device consists of a temporal sensor, a syringe pump, a
temperature controller, one inlet connecting the syringe unto the device, one outlet connecting waste tube, and a vacuum. PDMS polydimethylsiloxane
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Functional analysis, flow field simulation, and statistical
analysis
Details of the materials and methods used for RNA ex-
traction, quantitative real-time PCR, immunofluorescent
staining, flow cytometry analysis, uptake of low-density
lipoprotein (LDL), urea production assay, flow field
simulation and observation, and statistical analysis are
described in Additional file 1.
Results
Design, assembly, and performance test of the
bio-microfluidic culture system
A five-layered microfluidic device assembled from one
layer of PS, patterned PDMS, patterned glass, and
PMMA adaptors was designed and fabricated (Fig. 1a).
Together with the other components of the bio-
microfluidic system, the device was effectively utilized
for the maintenance and hepatic differentiation of MSCs
(Figs. 1b and 2). Since the force generated by the flow
rate of the culture medium can influence the prolifera-
tion and differentiation of MSCs, the perfusion perform-
ance in our system was initially simulated and tested
(Fig. 1c, d). We aimed at maintaining a constant flow
rate and homogeneous medium flow of media in the cell
culture chamber. The simulated field of velocity distri-
bution is illustrated in Fig. 1c. The simulation result
showed a uniform flow profile in the culture region of
the microfluidic device. In addition, the distribution of
rhodamine showed that the flow field near the center
line and the margin was uniform (Fig. 1d) and matched
the simulation result. The Reynolds number (Re) of our
microfluidic device for a 100 μl/hour flow rate was 3.6 ×
10–5. The flow is considered laminar flow when Re is
smaller than 2100, and turbulent flow when larger than
4000 [50]. The 100 μl/hour flow rate in our device was
therefore a laminar flow.
Efficiency of air bubble removal was further validated.
The air bubble-removal structure based on the principle
of negative pressure prevented experimental failures and
inconsistencies of experimental data caused by air bubble
interferences inside the culture chamber. Figure 1e is the
schematic representation of the air bubble-removal struc-
ture. The material of the barrier wall between the micro-
fluidic channel and the negative-pressure channel was
PDMS. When air bubbles enter the microfluidic channel
along with culture medium, they can be removed by the
air bubble-removal structures by applying negative pres-
sure through the gas-permeable PDMS. A movie of this
process demonstrates the slow disappearance of a large air
bubble injected into the microchannel of the device
12 hours previously (see Additional file 2: Video 1). The
result showed that the “bubble traps” within the device
were effective for removing the air bubbles. After valid-
ation of the quality of the device and performance of the
perfusion system, the microfluidic device was used for the
subsequent experiments of proliferation and differenti-
ation of MSCs.
Morphology, proliferation, pH, and immunophenotype of
MSCs cultured under the microfluidic device
Prior to the induction of hepatic differentiation of MSCs,
the proliferation and expression of stemness markers of
MSCs of cells cultured in the microfluidic device and the
culture dish were validated. After 3 days of culturing, the
cells showed a well-adhered and healthy morphology in
both the microfluidic device and the culture dish (Fig. 3a).
Also, the cell distribution on PS was homogeneous in both
groups. The growth curves of mouse MSCs were similar in
both the culture dish and the microfluidic device after
9 days of culture (Fig. 3b). However, we did observe a sig-
nificant difference in proliferation rates of human MSCs
between those cultured in the culture dish and those cul-
tured in the microfluidic device under different flow rates
(Additional file 1: Figure S3). We concluded that the cell
viability of mouse MSCs cultured in the microfluidic device
was no different from that of MSCs cultured in the culture
dish.
Previous studies have shown that an optimum pH
value is critical for cells to achieve high confluence and
efficient enzyme activity [43]. The pH level of the cul-
ture medium in the microfluidic device and culture dish
was therefore measured during the first 3 days of cultur-
ing. The result showed that the pH value of the medium
in the microfluidic device was maintained at about 7.3,
but decreased from 7.4 to 6.8 in the culture dish and
continued to decrease over time (Fig. 3c).
To investigate whether the microfluidic system has an
influence on MSC phenotype during maintenance, the ex-
pressions of cell surface markers of MSCs after 3 days of
culture in the microfluidic device and culture dish were
analyzed by flow cytometry. Figure 4 shows that most
MSCs cultivated in microfluidic devices and culture dishes
expressed the standard MSC surface markers, such as
CD29 and Sca-1. Although mouse MSC surface markers
are previously known to be CD34-negative and CD105-
positive cells, studies have shown that certain mouse
MSCs are CD34-positive [51]; in addition, CD105-positive
and CD105-negative mouse MSCs represent two inde-
pendent subpopulations that maintain their properties
upon several passages [52]. The mouse MSCs we used in
this study are therefore another bone marrow subpopula-
tion (CD34-positive and CD105-negative). Moreover, the
results showed that the surface markers of MSCs
remained unchanged after the 3-day culture in the micro-
fluidic system. In addition, we tested the expression of sur-
face markers in MSCs cultured in the static culture dish
and microfluidic device at day 0. Comparative expression
of surface markers in mouse MSCs cultured in the static
Yen et al. Stem Cell Research & Therapy  (2016) 7:120 Page 5 of 13
culture dish and microfluidic device at day 0 and day 3 are
shown in Additional file 1: Figure S4. The results demon-
strate that the expression of surface makers at day 0 is al-
most the same as that at day 3. MSCs cultured in both
environments were therefore similar and both have the
potential to further differentiate into hepatocytes. Because
the expressions of MSC surface markers in the microflui-
dic system and the static culture system were similar, a
comparison of hepatic differentiation between the two
systems was dependable.
Hepatic differentiation of MSCs in the microfluidic device
The cellular morphology, gene expression level, protein
level, and functional activity of differentiated hepatocyte-
like cells during hepatic MSC differentiation in the
microfluidic device were compared with those in the
culture dish. Cellular morphology was observed during
the first 7 days of hepatic differentiation using step-1
induction medium. The morphology of MSCs in both
the microfluidic device and the culture dish showed an
elongated and spindle-like shape form during the first
7 days of induction. The cellular morphology of MSCs
gained a cuboidal shape after 14 days of step-2 medium
induction both in the device and in the dish (Fig. 5a).
This result indicated that the cellular morphology of
MSCs was not influenced by flow generated in the
microfluidic device culture system. Furthermore, the
time-lapse movie (see Additional file 3: Video 2) shows
Fig. 3 Cell morphology and growth kinetics of MSCs cultured in the culture dish and microfluidic device. a MSCs were seeded at a density of
3 × 103 cells/cm2 in the microfluidic device and culture dish for 3 days. The cell morphology was compared between the two groups and
showed that the cells exhibited a well-adhered and healthy morphology in both groups. Scale bar= 100 μm. b Growth population curve of MSCs cultured
in the culture dish and microfluidic device showed that the growth curves of MSCs cultured in both groups were almost similar from 0 to 9 days. c The
pH value of the culture medium was monitored, measured, and compared within 4 days in both groups. The pH value in the static culture dish group
gradually decreased over time, while the pH value in the microfluidic system remained constant after several days of culture
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no difference of cellular morphology during 21 days of
hepatic differentiation between cells cultured in the de-
vice and in the culture dish.
To investigate whether there were significant differences
in gene expression of hepatic markers between the two
environments, the expressions of hepatocyte-associated
genes were detected by RT-PCR at day 21 of hepatic dif-
ferentiation of MSCs. The result showed that the expres-
sions of liver-associated genes were upregulated in both
environments (Fig. 5b). The hepatic differentiation of
MSCs in the microfluidic device showed an almost 4-fold
to 5-fold increase of liver-associated gene expression com-
pared with that in the culture dish (Fig. 5b). In addition,
Fig. 5c shows the comparative gene expression of hepatic
differentiated MSCs in the culture dish and the microflui-
dic device during 21 days. The result shows that the gene
expressions of hepatocyte nuclear factor 4 (HNF4) and
alpha fetoprotein (AFP) at day 14 between the dish group
Fig. 4 Immunophenotype analysis of mouse MSCs cultured in the culture dish and microfluidic device. Expression of surface markers in mouse
MSCs cultured in the a static culture dish and b microfluidic device at day 3 were validated using flow cytometry. Representative histograms
confirmed that the MSCs did not express antigen CD34 but expressed stem cell surface markers CD29, CD105, and SCA-1
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and the microfluidic device group are similar. This means
that the hepatic differentiation in the microfluidic device
is not delayed. Also, differences of protein expression be-
tween the two environments were investigated. Immuno-
fluorescence staining for albumin after 21 days of hepatic
differentiation in the two cultural systems is shown in
Fig. 6a. The fluorescence intensity of albumin in the
microfluidic device was stronger compared with that in the
culture dish. Furthermore, LDL uptakes from differentiated
MSCs in both environments were assessed by staining the
cells at day 21 with LDL assay dye. The number of LDL-
positive cells were counted and compared. As shown in
Fig. 6b, the percentage of LDL-positive MSCs from the
microfluidic device was higher than that from the culture
Fig. 6 Protein expression of differentiated hepatocyte like-cells from MSCs in the culture dish and microfluidic device. Expression of a marker of
functional hepatocyte (albumin) was assessed by immunofluorescence staining from differentiated hepatocyte-like cells after 21 days of induction
(a). Cells were observed under a light microscope at 200× magnification. Scale bar= 100 μm. In addition, comparison of LDL uptake and urea production
of MSCs cultured in the (b) culture dish and (c) microfluidic device are shown. MSCs were fixed at day 21 and stained with LDL uptake in both cell groups.
The percentage of LDL-positive MSCs at day 21 is shown in (b). LDL uptake was higher in the MSCs cultured in microfluidic device compared
with those cultured in the culture dish. (c) After 21 days of two-step induction, higher urea production was observed in hepatocyte-like cells
growing in the microfluidic device than in the culture dish. Data presented as mean ± SD (n = 3). ***P < 0.001, Student's t test. DAPI 4′,6-
diamidino-2-phenylindole. LDL low-density lipoprotein
(See figure on previous page.)
Fig. 5 Morphology and gene expression profile of hepatic differentiated MSCs using the microfluidic system. a MSCs were grown in the culture
dish and microfluidic device and were allowed to differentiate into hepatocyte-like cells within 21 days using the two-step hepatic induction
protocol. Cells were observed under a light microscope. Scale bar = 100 μm. b Comparative gene expression of hepatic differentiated MSCs in the
culture dish and the microfluidic device after 21 days of two-step induction. Hepatocyte-like cells derived from MSCs in the microfluidic system
expressed higher hepatocyte-specific marker genes than those in the culture dish. Data presented as mean ± SD (n = 3). *P < 0.05, **P < 0.01,
Student’s t test. c Comparative gene expression of hepatic differentiated MSCs in the culture dish and the microfluidic device during 21 days.
Gene expressions of HNF4 and AFP at day 14 between the dish group and the microfluidic device group are similar. Data presented as mean
± SD (n = 3). *P < 0.05, **P < 0.01, Student’s t test
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dish. Based on previous studies showing that functional he-
patocytes are capable of producing urea [53], a urea func-
tional assay was used to assess the bio-activities of
hepatocyte-like cells (Fig. 6c). The result showed that
MSCs in the microfluidic device produced 2.5-fold more
urea than that in the culture dish. Collectively, based on
these results, we concluded that the bio-microfluidic sys-
tem efficiently generated more differentiated hepatocyte-
like cells from MSCs compared with the conventional
static culture.
Discussion
In this study, a perfusion-based microfluidic system was
designed to enhance the production of differentiated
hepatocytes from MSCs. The design showed substantial
advantage in promoting hepatogenesis of MSCs. Our
design has two major advantages over other similar de-
vices which use negative pressure to seal the open cover,
such as the hybrid microfluidic–vacuum system [54, 55].
First, the use of LDW techniques reduced the fabrication
time of our microfluidic system from days to hours com-
pared with the conventional micro-electromechanical
techniques [48]. Also, the fabrication of a large culture
chamber is made easy with the help of LDW techniques.
Second, unlike other previous designs [54, 55], cells are
not pressed against the microfluidic device at the edges of
culture chamber during assembly due to a close match
between the cell culture region and the culture chamber
in our system; this design prevents cell damage during
assembly. In addition, the microfluidic device can be
reversibly bonded and unbonded to the culture substrate,
which is useful for further immunocytochemistry or
manipulation of cell colonies. For example, unwanted col-
onies can be removed easily without affecting the healthy
ones during maintenance. This device may also be suitable
for the differentiation of ESCs or induced pluripotent
stem cells (iPSCs).
Besides a larger cell culture surface area, a geometry that
allows uniform flow distribution within the culture cham-
ber is also a featured characteristic which confers several
advantages for hepatic differentiation of MSCs. The
culture chamber of our microfluidic device (culture
area ≥ 400 mm2) was significantly larger than that pre-
viously reported (culture area = 7 mm2) [20]. Incorpor-
ating this device into an automated system, scale-up
production for cell therapy is possible. Moreover, the
flow field distribution of the culture medium inside the
chamber is more uniform because of the quadrilateral
geometry of the culture chamber, because the flow
field of a rectangular chamber creates a more uniform
flow (Fig. 1c, d). On the contrary, uneven flow occurs
in a circular chamber (Additional file 1: Figure S5).
Hence, a more homogeneous flow distribution within the
culture chamber can be achieved in our device, which
offers a favorable environment for hepatic differentiation
of MSCs.
The microfluidic system, which mimics the shear flow
microenvironment, theoretically confers advantages over
the static culture system. It supplies a continuous flow
of fresh medium and facilitates constant removal of
metabolic wastes, which provides a constant microenvir-
onment to maintain cell viability and function over a
longer culture period. On the contrary, there are inher-
ent limitations in the traditional in-vitro static culture
systems, such as nutrient supply and metabolic end-
product accumulation, including release of toxins that
negatively influences the cell growth [56]. The utilization
of our bio-micofluidic device with a favorable environment
efficiently facilitates and accelerates hepatic differentiation
of MSCs. In addition, a previous study has demonstrated
that the microenvironment is essential for the stemness
properties of stem cells [57]. The cellular microenviron-
ments of MSCs in the microfluidic device and the culture
dish were similar, and so was the cell viability of MSCs.
The microenvironment in the culture chamber is the
key for efficient hepatic differentiation of MSCs in this
study. The continuous flow not only constantly supplies
nutrients for hepatic differentiation but also removes the
unhealthy cells that loosely attached onto the culture
chamber. As a consequence, hepatocyte-like cells with
homogeneous and favorable functional activities are
obtained. A previous study indicates that removal of
cell-secreted factors suppresses cell growth and differen-
tiation [58]. However, this action did not seem to sup-
press cell growth and differentiation in our study. This
might be due to the use of a two-step hepatic differenti-
ation protocol which offers necessary growth factors to
support hepatogenesis [9]. These factors can be main-
tained at a relatively stable and higher concentration in
the microfluidic system compared with the static culture.
A higher expression of hepatic marker genes in the
microfluidic device group may be attributable to the
mechanical microenvironment as well as more homoge-
neous cell distribution in the device.
Shear stress plays a crucial role in regulating prolifera-
tion, differentiation, and cellular morphology of MSCs
[59–61]. The shear stress generated in our microfluidic
device was much lower (0.00142 Dyne/cm2) than those
previously reported to regulate the proliferation and
osteogenic differentiation of MSCs (0.3–2.7 Dyne/cm2)
[59–61]. It did not affect the lineage commitment of
MSCs because there were no significant difference
between the microfluidic system and static culture in
surface immunophenotype after 3 days of maintenance
(Fig. 4). This means that shear stress was not a key fac-
tor for stemness properties of MSCs in our study. More-
over, a previous study indicates that low shear stress
could further stimulate maturation signals through
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sensory systems on polarized hepatic cells [62]. Indeed,
higher expression of hepatic marker genes was observed
in the microfluidic device and the mechanical signals
might have contributed to functional maturation of
hepatocyte-like cells.
Based on our results, MSCs in the microfluidic device
after 3 weeks of hepatic induction expressed a high level
of AFP and HNF4. Because AFP is specifically expressed
in hepatocyte progenitors, it is therefore one of the indi-
cators for hepatic differentiation [63, 64]. The high level
of AFP after 3 weeks of hepatic differentiation means
that use of the microfluidic device can accelerate the
hepatic differentiation. The results indicated that both
hepatocyte progenitors (AFP high expression) and
matured hepatocytes (HNF4 high expression) in the
microfluidic device are greater than those in the culture
dish, due to the optimal differentiation conditions. Since
previous studies have indicated that hepatic progenitor
cells (or fetal liver cells) possess greater regeneration
potential than fully matured hepatocytes in experimental
liver failure models [49, 65, 66], the cells differentiated
in the microfluidic device should be suitable for cell
therapy compared with those generated from 2D static
culture. The hepatic differentiation from MSCs in the
microfluidic device is therefore a more efficient method
than that in the culture dish.
Conclusions
An innovative microfluidic system that allows homoge-
neous cell seeding and real-time observation of cell
morphology has been developed. The system efficiently
generates hepatocyte-like cells from MSCs with more
rapid functional maturation than a conventional static
culture system. This microfluidic system may be further
developed for large-scale production of hepatocyte-like
cells to meet the high demand in the cell therapy indus-
try. More efforts will be devoted to further scale-up and
automation of this novel device.
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